Literature DB >> 21960938

Hepatitis C virus and insulin resistance/diabetes mellitus.

Dawn M Torres1, Stephen A Harrison.   

Abstract

Entities:  

Year:  2008        PMID： 21960938      PMCID： PMC3096110     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  13 in total

1.  Severe insulin resistance in a treatment-naive chronic hepatitis C patient.

Authors:  Omar Khokhar; Jacqueline Fischer
Journal:  Gastroenterol Hepatol (N Y)       Date:  2008-08

2.  Prevalence of diabetes mellitus in patients with end-stage liver cirrhosis due to hepatitis C, alcohol, or cholestatic disease.

Authors:  N N Zein; A S Abdulkarim; R H Wiesner; K S Egan; D H Persing
Journal:  J Hepatol       Date:  2000-02       Impact factor: 25.083

3.  Increased insulin resistance and hyperinsulinemia in patients with type 2 diabetes and chronic hepatitis C.

Authors:  Beatriz R Oliveira; Otávio Magalhães; Tania W Furlanetto; Marcello C Bertoluci
Journal:  Diabetes Res Clin Pract       Date:  2007-09-27       Impact factor: 5.602

4.  Impact of diabetes mellitus on prognosis of patients infected with hepatitis C virus.

Authors:  Yuki Kita; Eishiro Mizukoshi; Toshinari Takamura; Masaru Sakurai; Yoshiko Takata; Kuniaki Arai; Tatsuya Yamashita; Yasunari Nakamoto; Shuichi Kaneko
Journal:  Metabolism       Date:  2007-12       Impact factor: 8.694

5.  Clinical implications of hepatogenous diabetes in liver cirrhosis.

Authors:  Andreas Holstein; S Hinze; E Thiessen; A Plaschke; E-H Egberts
Journal:  J Gastroenterol Hepatol       Date:  2002-06       Impact factor: 4.029

6.  Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis.

Authors:  Rami Moucari; Tarik Asselah; Dominique Cazals-Hatem; Hélène Voitot; Nathalie Boyer; Marie-Pierre Ripault; Rodolphe Sobesky; Michèle Martinot-Peignoux; Sarah Maylin; Marie-Hélène Nicolas-Chanoine; Valérie Paradis; Michel Vidaud; Dominique Valla; Pierre Bedossa; Patrick Marcellin
Journal:  Gastroenterology       Date:  2007-11-12       Impact factor: 22.682

7.  Interplay between oxidative stress and hepatic steatosis in the progression of chronic hepatitis C.

Authors:  Matteo Vidali; Marie-Francoise Tripodi; Alesandra Ivaldi; Rosa Zampino; Giuseppa Occhino; Luciano Restivo; Salvatore Sutti; Aldo Marrone; Giuseppe Ruggiero; Emanuele Albano; Luigi E Adinolfi
Journal:  J Hepatol       Date:  2007-12-03       Impact factor: 25.083

8.  Insulin resistance and response to therapy in patients infected with chronic hepatitis C virus genotypes 2 and 3.

Authors:  Hossein Poustchi; Francesco Negro; Jason Hui; Ian Homer Y Cua; Laura Rubbia Brandt; James G Kench; Jacob George
Journal:  J Hepatol       Date:  2007-10-01       Impact factor: 25.083

Review 9.  Impact of diabetes on the severity of liver disease.

Authors:  Ingrid J Hickman; Graeme A Macdonald
Journal:  Am J Med       Date:  2007-10       Impact factor: 4.965

10.  In overweight patients with chronic hepatitis C, circulating insulin is associated with hepatic fibrosis: implications for therapy.

Authors:  Ingrid J Hickman; Elizabeth E Powell; Johannes B Prins; Andrew D Clouston; Susan Ash; David M Purdie; Julie R Jonsson
Journal:  J Hepatol       Date:  2003-12       Impact factor: 25.083
View more
  2 in total

1.  Metformin and daclatasvir: absence of a pharmacokinetic-pharmacodynamic drug interaction in healthy volunteers.

Authors:  Elise J Smolders; Angela Colbers; Clara T M M de Kanter; Kirsten Velthoven-Graafland; Leonie T Wolberink; Noor van Ewijk-Beneken Kolmer; Joost P H Drenth; Rob E Aarnoutse; Cees J Tack; David M Burger
Journal:  Br J Clin Pharmacol       Date:  2017-06-06       Impact factor: 4.335

2.  Changes of serum omentin-1 levels and relationship between omentin-1 and insulin resistance in chronic hepatitis C patients.

Authors:  Walaa Moustafa Hussein Nassif; Ashraf Ismail Amin; Zeinab Abdeltawab Hassan; Dalia Hussein Abdelhafiz Abdelaziz
Journal:  EXCLI J       Date:  2013-11-04       Impact factor: 4.068
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.